Abstract
The objective of this study was to screen for acromegaly by application of a simple questionnaire in patients seen at primary health care units. A total of 17,000 patients of both genders >18 and <70 years seen by general practitioner were interviewed. Patients with known pituitary disease and pregnant women were excluded. A simple questionnaire was applied to the patients: Has your shoe size increased over the last 5 years? Did you have to change your wedding ring or ring over the last 5 years because it became tight? In one patient, the diagnosis of acromegaly was suspected by the physician. Among the remaining patients, 178 (1%) responded positively to one of the items of the questionnaire and were submitted to IGF-1 measurement. Five patients had persistently elevated IGF-1 and inadequate suppression of GH in the OGTT (without other conditions associated with GH or IGF-1 elevation). One of these patients presented a normal pituitary upon magnetic resonance imaging and adenoma was detected in the other four; two presented the typical facies and two others reported changes in physiognomy (confirmed by the comparison of photographs), in addition to the enlargement of extremities. The present investigation suggests a much higher prevalence of acromegaly in the adult population than that reported traditionally. We propose that screening based on phenotypic alterations is cost-effective since these changes occur early and almost universally in acromegaly and are uncommon in the general population.
Similar content being viewed by others
References
Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355:2558–2573
Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006; Acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 72:203–208
Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91:4769–4775
Cannavò S, Ferraù F, Ragonese M, Curtò L, Torre ML, Magistri M, Marchese A, Alibrandi A, Trimarchi F (2010) Increased prevalence of acromegaly in a highly polluted area. Eur J Endocrinol 163:509–513
Schneider HJ, Sievers C, Saller B, Wittchen HU, Stalla GK (2008) High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clin Endocrinol (Oxf) 69:432–435
Rosario PW (2011) Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population. Pituitary. doi:10.1007/s11102-010-0281-0
Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102–152
Melmed S (2001) Acromegaly and cancer: not a problem. J Clin Endocrinol Metab 86:2929–2934
Psaras T, Milian M, Hattermann V, Freiman T, Gallwitz B, Honegger J (2011) Demographic factors and the presence of comorbidities do not promote early detection of Cushing’s disease and acromegaly. Exp Clin Endocrinol Diabetes 119:21–25
Nachtigall L, Delgado A, Swearingen B, Lee H, Zerikly R, Klibanski A (2008) Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab 93:2035–2041
Ezzat S, Forster MJ, Berchtold P (1994) Acromegaly: clinical and biochemical features in 500 patients. Medicine 73:233–240
Molitch ME (1992) Clinical manifestations of acromegaly. Endocrinol Metabol Clin N Am 21:597–614
Mercado M, Espinosa de los Monteros AL, Sosa E (2004) Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease. Horm Res 62:293–299
Rosario PW (2010) Normal values of serum IGF-1 in adults: results from a Brazilian population. Arq Bras Endocrinol Metabol 54:477–481
Rosario PW, Furtado M (2008) Growth hormone after oral glucose overload: revision of reference values in normal subjects. Arq Bras Endocrinol Metabol 52:1139–1144
Freda PU (2009) Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant? Clin Endocrinol 71:166–170
Doppman JL, Miller DL, Patronas NJ, Oldfield EH, Merriam GR, Frank SJ, Flack MR, Weintraub BD, Gorden P (1990) The diagnosis of acromegaly: value of inferior petrosal sinus sampling. AJR Am J Roentgenol 154:1075–1077
Daud S, Hamrahian AH, Weil RJ, Hamaty M, Prayson RA, Olansky L (2011) Acromegaly with negative pituitary MRI and no evidence of ectopic source: the role of transsphenoidal pituitary exploration? Pituitary. doi:10.1007/s11102-009-0205-z
Lonser RR, Kindzelski BA, Mehta GU, Jane JA Jr, Oldfield EH (2010) Acromegaly without imaging evidence of pituitary adenoma. J Clin Endocrinol Metab 95:4192–4196
Acknowledgments
This study was supported by grants from Laboratórios Pfizer Ltda (Brazil).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosario, P.W., Calsolari, M.R. Screening for acromegaly by application of a simple questionnaire evaluating the enlargement of extremities in adult patients seen at primary health care units. Pituitary 15, 179–183 (2012). https://doi.org/10.1007/s11102-011-0302-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-011-0302-7